Meta-analysis of Selective Serotonin Reuptake Inhibitors (SSRIs) Compared to Tricyclic Antidepressants (TCAs) in the Efficacy and Safety of Anti-depression Therapy in Parkinson's Disease(PD) Patients

AuthorBao-Yue Qiuen
AuthorJun-Xiao Qiaoen
AuthorJiang Yongen
Issued Date2014-10-31en
AbstractTo assess the efficacy and safety of selective serotonin reuptake inhibitors(SSRIs) and tricyclic antidepressants(TCAs) in treatment of Parkinsonian depression.en
DOIhttps://doi.org/10.22037/ijpr.2014.1596en
KeywordMeta-analysisen
KeywordSelective serotonin reuptake inhibitors (SSRIs)en
KeywordTricyclic anti-depressants (TCAs)en
KeywordEfficacyen
KeywordComplicationen
PublisherBrieflandsen
TitleMeta-analysis of Selective Serotonin Reuptake Inhibitors (SSRIs) Compared to Tricyclic Antidepressants (TCAs) in the Efficacy and Safety of Anti-depression Therapy in Parkinson's Disease(PD) Patientsen
TypeOriginal Articleen

Files